GPX4-dependent ferroptosis governs ILC2 homeostasis and colitis progression.

Saved in:
Bibliographic Details
Title: GPX4-dependent ferroptosis governs ILC2 homeostasis and colitis progression.
Authors: Liu G; Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.; Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China., Wang Y; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China., Huang H; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China., Wang J; Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China., Yang J; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China., Wu J; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin, China., Cao H; Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin, China., Zhang Y; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China., Jing Y; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China., Zhou P; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China., Yu Y; Department of Pharmacology, Tianjin Key Laboratory of Inflammatory Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China., Chen C; Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China., Liu Q; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China. qliu@tmu.edu.cn., Zhou J; Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China. zhoujie@tmu.edu.cn.; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China. zhoujie@tmu.edu.cn.
Source: Cellular & molecular immunology [Cell Mol Immunol] 2026 Apr; Vol. 23 (4), pp. 367-382. Date of Electronic Publication: 2026 Feb 09.
Publication Type: Journal Article
Journal Info: Publisher: Chinese Society of Immunology Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN: 16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2042-0226
DOI:10.1038/s41423-026-01388-w